|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4985 | |
| C07D 471/04 | |||
| A61K 31/7072 | |||
| A61K 31/522 |
| (11) | Patento numeris | 3229804 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15867817.7 |
| Europos patento paraiškos padavimo data | 2015-12-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/063851 |
| Data | 2015-12-04 |
| (87) | Numeris | WO 2016/094198 |
| Data | 2016-06-16 |
| (30) | Numeris | Data | Šalis |
| 201462089570 P | 2014-12-09 | US |
| (72) |
GRAHAM, Thomas, H., US
EMBREY, Mark, W., US
WALJI, Abbas, US
WADDELL, Sherman, T., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS |
| SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS |